case_images: PMC11439363_01
case_images: Comparative changes in pulmonary infection (A) and liver abscess lesions (B) before and after treatment. The arrows in Figure 1 represent the changes of liver abscess lesions before and after treatment.
case_images: IDR-17-4161-g0001.jpg
case_images: PMC11439363_01_IDR-17-4161-g0001.jpg
case_images: f0001
case_images: Computed tomography (CT) scans revealed infectious lesions in both lungs and a low-density lesion in the right lobe of the liver (Figure 1). Follow-up CT scans showed significant absorption of the pulmonary infection and liver abscess lesions (Figure 1).
case_images: Changes in intracranial lesions on cranial MRI at various time points during the disease (days 1, 37, 50, 72, and 90, respectively). MRI, magnetic resonance imaging.
case_images: IDR-17-4161-g0002.jpg
case_images: PMC11439363_01_IDR-17-4161-g0002.jpg
case_images: f0002
case_images: Brain magnetic resonance imaging (MRI) showed patchy long T1 and T2 signals in the bilateral basal ganglia, corpus callosum semioval region, genu, and splenium of the corpus callosum, with high signals on diffusion-weighted imaging (Figure 2). However, due to unsatisfactory control of intracranial infection lesions on brain MRI (Figure 2) and the gradual formation of brain abscesses, on day 37 of the disease course, we switched the treatment to a combination of intravenous meropenem (2.0 g/dose, three times daily) and CAZ-AVI (2.5 g/dose, three times daily). CSF indicators showed improvement compared to previous results, and follow-up brain MRI indicated absorption and reduction of brain abscesses (Figure 2). Currently, the general condition of the patient is good, and he is undergoing regular follow-up in our department.
case_images: Illustration of changes in the CSF, cranial MRI findings, and treatment course of the patient.
case_images: IDR-17-4161-g0003.jpg
case_images: PMC11439363_01_IDR-17-4161-g0003.jpg
case_images: f0003
case_images: The changes in the CSF of the patient and the treatment course are depicted in Figure 3.